A New Modality for Diabetic Wound Care


CME: A New Modality for Diabetic Wound Care

Perry Mayer, MD, Medical Director, The Mayer Institute (TMI), Hamilton, Ontario

Joseph Gabriele, PhD, Chief Scientific Officer, Delivra Inc., Burlington, Ontario

Farzan Dadfar, Pharmacist Manager, NKS Health, Toronto, Ontario

This learning program has been developed for primary care physicians, educators, and other health professionals. Learners will utilize this program to assist with the diagnosis, sound management, and appropriate treatment of Diabetic Foot Ulcers in patients.

  • This program runs in a sequence, and is accompanied by informative illustrations, and animations.
  • Best viewed with accompanying voice-over narration.
  • You may pause, rewind, or fast-forward at any point.
  • Slides with links to figures or tables will pause automatically to allow the user time to view the additional material.

  • Quick understanding of the importance of diagnosing and treating DFUs as one of the often overlooked complications of Diabetes
  • Learning how topical doxycycline hyclate can be used for the treatment of “stalled” diabetic ulcers
  • Understanding how doxycycline hyclate compounded in the Delivra transdermal base cream provides better stability and deeper penetration of the active ingredient
  • Learning how Delivra-DX™ can be utilized in two real life DFU case examples
  • Learning how Delivra-DX™ will be compounded and safely delivered across Canada direct to patients with a valid prescription

Views and opinions in this program are of the faculty and not necessarily endorsed by, or reflective of, those of the publisher or editors of Health Plexus.

The development of this educational program was supported by an unrestricted educational grant from Delivra Corporation.